NCT00208611终止2 期
Assessment of Cobalamin Status and Responses to Supplementation in Patients With Parkinson's Disease : a Pilot Study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 终止
- 入组人数
- 57
- 试验地点
- 2
- 主要终点
- Vitamin B12 concentration
研究概览
简要总结
Based on Parkinson's disease (PD)/vitamin B12 deficiency symptom overlap and PD patients' propensity to avoid protein (the dietary source of vitamin B12), this study proposes to prospectively investigate the vitamin B12 status of PD patients over time. In addition, this study will provide critical pilot data evaluating the efficacy of treating those patients considered to have below-normal vitamin B12 levels in serum. Further, it will also explore the concept that supplementing PD patients having "low-normal" vitamin B12 levels with vitamin B12 improves either the non-motor PD symptoms or homocysteine levels in PD patients receiving levodopa.
Study Hypotheses:
- Serum cobalamin (B12) concentrations in patients with Parkinson's disease (PD) are significantly lower than B12 concentrations in a) cohabiting spousal caregiver controls; and b) population-based, age-matched controls.
- Supplementation with B12 in levodopa-treated PD patients with low (<200 pg/ml) or low-normal (200-300 pg/ml) serum B12 levels is associated with significant improvement in their non-motor symptoms and reduces total plasma homocysteine concentration [Hcy], a known biomarker for risk of dementia and cerebrovascular disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients seen in Emory Healthcare System at least once between 1/1/2002 and 05/31/2006 with idiopathic Parkinson's disease (defined as):
- •>2 of cardinal signs/symptoms of Parkinson's disease (bradykinesia, tremor, rigidity)
- •>50% improvement of symptoms when dopaminergic therapy started
- •Cohabiting spousal caregivers (without Parkinson's disease) of patients enrolled in study are also eligible (but not required) to participate
- •Coexisting depression, if present, is stable
- •Normal thyroid screen (done at Screening Visit or at Emory Healthcare System within 3 months of Screening Visit)
- •Males must have normal fasting testosterone levels (done at Screening visit or within 6 months of Screening Visit)
排除标准
- •Unstable medical conditions (terminal cancer, angina, etc) which could interfere with study assessments or put patient at risk for not completing the assessments.
- •Dopaminergic-unresponsive parkinsonism (i.e., patient has suspected multiple systems atrophy (MSA), vascular or another form of parkinsonism)
- •Prior history of vitamin B12 deficiency or taking vitamin B12 supplements or injections (single multivitamin supplements are not an exclusion criteria)
- •Untreated testosterone or thyroid abnormality
结局指标
主要结局
Vitamin B12 concentration
时间窗: Baseline
次要结局
未报告次要终点
研究者
Marian L. Evatt
Assistant Professor
Emory University
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Cobalamin Deficiency - Diagnosis and TherapyVitamin B 12 DeficiencyNCT04243707University Hospital, Basel, Switzerland3,000
已完成
不适用
Cobalamin deficiency in primary care: a placebo-controlled, double-blind, randomized trialCobalamin deficiencyNutritional, Metabolic, EndocrineISRCTN22063938Medical Outpatient Clinic, University of Lausanne (Switzerland)40
已完成
不适用
The Effect of Cervical Spinal Stabilization Exercises in Patients With Parkinson's DiseaseParkinson DiseaseNCT03854747Hacettepe University18
已完成
不适用
Profile of Depressive Symptoms in Parkinsons DiseaseDepressionParkinson DiseaseNCT00349310Boehringer Ingelheim1,018
已完成
不适用
Interaction of Cobalamin Status With Nitrous Oxide in Relation to Postoperative Cognitive Changes in the ElderlyAvitaminosisDelirium, Dementia, Amnestic, Cognitive DisordersNCT00212147National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)444